glp-1 for autoimmune disease Glucagon-like peptide and its receptor agonists the treatment of rheumatic diseases GLP-1 Medications for Arthritis &

Am J Physiol Endocrinol Metab 299: E62-68, 2010

This article was previously distributed in the August 22, 2023, educational email of the Patient Safety Authority, available at About the Author Patient Safety Authority (patientsafety.pa.gov) is an independent state agency that oversees the Pennsylvania Patient Safety Reporting System (PA-PSRS), the largest database of its kind in the United States.

Are GLP-1 drugs safe

Injectable medications, while effective, can deter some individuals from beginning or continuing treatment

Phase High escalation Weeks Weeks 13-16 Weekly Dose 6 mg Notes Phase 3 added this intermediate step